Thiamine pyrophosphate
|
Basic information |
| Metabolite name | Thiamine pyrophosphate |
 | HMDB0001372 |
 |
C00068 |
 |
1132 |
| Synonyms | NA |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | Thiamine pyrophosphate |
| HMDB0001372 |
|
C00068 |
|
1132 |
| Synonyms | NA |
| No. of studies | 5 |
|
Relationship between Thiamine pyrophosphate and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Down |
| Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M664 | Type1 | CSDS group vs. control group | Hippocampus | C57BL/6 J mouse | Up |
| Study M762 | Type1 | corticosterone group vs. control group | Liver | Wistar rat | Up |
| Study M762 | Type2 | corticosterone + metformin group vs. corticosterone group | Liver | Wistar rat | Down |
| Study M898 | Type1 | end-stage renal disease with depression group vs. end-stage renal disease without depression group | Serum | Human | Down |